Medical News

RSS Latest News on Primary Aldosteronism

PA Foundation in the News

  • Primary Aldosteronism AllianceIn September 2022, the PA Foundation announced the creation of a multistakeholder alliance to drive diagnosis and treatment of primary aldosteronism.
  • Dietary Sodium Global Call to ActionThe PA Foundation is one of the co-authors of the World Hypertension League’s call to action published in May 2022 by the Journal of Human Hypertension.
  • BMJ Practice Series: Easily Missed?The PA Foundation co-authored the article of the BMJ Practice Series on primary aldosteronism. The open access article was published in April 2022.
  • Doctors Overlook a Curable Cause of High BPMIT’s magazine, Undark, featured the PA Foundation in an article of its February 2022 edition dedicated to primary aldosteronism.

Notable Publications of the Year

Primary Aldosteronism in the EROver 40% of patients presenting to the ER of an Australian tertiary health network met the criteria for PA testing. Only 2% were screened.

BPA and Primary Aldosteronism ScreeningImplementation of an EHR best-practice advisory yielded a screening rate of 14%. Most orders were placed by internists (40%) and primary care physicians (28%).

AVS and Asymmetrical Bilateral PAMultifocal, asymmetrical bilateral PA cannot be excluded by robust AVS lateralization. The study’s independent predictors of postoperative residual PA included Black race, AVS lateralization only at baseline, and CT-AVS disagreement.

68Ga-Pentixafor PET/CT and Subtyping of PAIn a study of 123 patients with adrenal micronodules, the sensitivity, specificity, and accuracy of 68Ga-pentixafor PET/CT in subtyping primary aldosteronism were 90.2%, 86.3%, and 89.4%, respectively. The accuracy of AVS examination was lower than that of PET/CT.

RSS Latest News on Hypertension